NCT00460798View on ClinicalTrials.gov

SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

356

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Renal Cell Carcinoma
Interventions
OTHER

Sutent: observational study

SUNIKA - A Non-Interventional Study With SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY